Expensive Menopause Supplements Offer No Advantage Over 6p Daily Multivitamin, Which? Finds

Emily Watson, Health Editor
4 Min Read
⏱️ 3 min read

A budget-friendly multivitamin from Asda costing just 6p per day has been found to be equally effective as premium menopause supplements that retail for hundreds of pounds annually, according to new research by consumer watchdog Which?.

The findings reveal a significant disparity in value for money across the menopause supplement market, where women are being charged premium prices for products that may not deliver additional health benefits compared to basic nutritional alternatives.

Comprehensive Testing Reveals Market Shortcomings

Which?’s team of nutrition experts conducted an extensive evaluation of 26 supplements specifically marketed towards women experiencing menopause, perimenopause, or those aged over 45. The researchers meticulously cross-referenced more than 78 active ingredients against current scientific evidence to assess their efficacy and nutritional value.

Shockingly, none of the tested products met the criteria for providing the appropriate balance or dosage of nutrients essential for menopausal support. During this life stage, calcium and vitamin D become particularly crucial for maintaining bone health as oestrogen levels decline, alongside other beneficial nutrients including magnesium, iron, zinc, iodine, selenium, B vitamins, and vitamins C, E, and K.

“Fairy-Dusting” and Missing Nutrients Undermine Product Value

Many of the expensive supplements were found to contain key nutrients in insufficient quantities – a practice known as “fairy-dusting” – while some omitted vital vitamins and minerals entirely. Additionally, numerous products combined traditional vitamins and minerals with botanical ingredients such as black cohosh, soy, and red clover, despite Which? discovering that the evidence supporting these plant-based compounds was “mixed” at best.

"Fairy-Dusting" and Missing Nutrients Undermine Product Value

Furthermore, many products contained these botanical elements at doses significantly below those utilised in clinical trials, raising questions about their therapeutic potential. Which? expressed concern that the supplements industry has become a “wild west,” with inadequate regulatory oversight failing to address misleading marketing claims and unsubstantiated medical assertions from companies capitalising on health anxieties.

Budget Alternative Provides Complete Nutritional Profile

Asda’s A-Z Multivitamins & Minerals emerged as a standout option, offering comprehensive nutritional support at a fraction of the cost – 6p daily or £22 annually. The product contains all essential vitamins along with 200mg of calcium and 100mg of magnesium, addressing key nutritional needs during menopause without the premium price tag.

Which? recommends that consumers opt for high-quality multivitamins and add targeted supplements only where medically necessary, rather than investing in costly all-in-one menopause formulations that may not provide superior benefits.

Why it Matters

This research has significant implications for the millions of women navigating menopause and perimenopause who may be spending hundreds of pounds annually on supplements that offer no additional benefit over affordable alternatives. Beyond the financial burden, the findings highlight serious concerns about transparency and regulation within the supplements industry, where marketing claims often outpace scientific evidence. For women seeking nutritional support during this transformative life stage, the message is clear: effective supplementation doesn’t require a premium price tag, and informed choices based on evidence rather than marketing can lead to both better health outcomes and substantial cost savings.

Why it Matters
Share This Article
Emily Watson is an experienced health editor who has spent over a decade reporting on the NHS, public health policy, and medical breakthroughs. She led coverage of the COVID-19 pandemic and has developed deep expertise in healthcare systems and pharmaceutical regulation. Before joining The Update Desk, she was health correspondent for BBC News Online.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy